oral l carnitine bioavailability L-carnitine modified nanoparticles target the OCTN2 transporter to improve the absorption of jujuboside B Low Bioavailability and High TMAO

Started with nutrition and behaviour change, moved into GLP-1 prescribing, and now expanding into the same verticals the longevity space has been quietly building in, energy, hormonal health, inflammation, sleep

Dose ranges are often species- and model-dependent, with rodent studies using body-weight-normalized doses (mcg/kg or mg/kg) that may be substantially different from the fixed doses used in primate or pharmacokinetic models

The structural basis for regulation of the glutathione transporter Ycf1 by regulatory domain phosphorylation

It is not intended for consumer purchase, self-administration, or use without proper professional supervision and training in aseptic technique and pharmaceutical handling